Endpoints News 2026-02-27 Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
Endpoints News 2026-02-26 Boehringer wins accelerated approval for first-line use of lung cancer drug
Endpoints News 2026-02-26 Protagonist to opt out of Takeda profit-sharing deal, will receive $400M in cash
Endpoints News 2026-02-26 Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News 2026-02-26 OrbiMed jumps to number one on the top 100 list of biotech venture investors